Syngen Biotech Co Ltd
TPEX:8279
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Syngen Biotech Co Ltd
TPEX:8279
|
TW |
|
T
|
Television Francaise 1 SA
XMUN:FSE
|
FR |
|
Shefa Gems Ltd
LSE:SEFA
|
IL |
|
HSBC Holdings PLC
LSE:HSBA
|
UK |
|
Stratasys Ltd
NASDAQ:SSYS
|
US |
|
P
|
Platinum Group Metals Ltd
AMEX:PLG
|
CA |
|
P
|
PARK & Bellheimer AG
F:PKB
|
DE |
|
Kedawung Setia Industrial Tbk PT
IDX:KDSI
|
ID |
|
G
|
Global Payments Inc
F:GLO
|
US |
|
U
|
United Rentals Inc
XMUN:UR3
|
US |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
Green Plains Inc
NASDAQ:GPRE
|
US |
|
S
|
Seafront Resources Corp
XPHS:SPM
|
PH |
|
Bravura Solutions Ltd
ASX:BVS
|
AU |
|
Surya Semesta Internusa Tbk PT
IDX:SSIA
|
ID |
|
Caspin Resources Ltd
ASX:CPN
|
AU |
|
I
|
ideaForge Technology Ltd
NSE:IDEAFORGE
|
IN |
|
Seche Environnement SA
F:SCB
|
FR |
|
A
|
Aker ASA
SWB:FKM
|
NO |
|
Ralph Lauren Corp
NYSE:RL
|
US |
|
U
|
Upson International Corp
XPHS:UPSON
|
PH |
|
S
|
Sevenet SA
WSE:SEV
|
PL |
|
SGS SA
F:SUV
|
CH |
|
Blue Sphere Corp
OTC:BLSP
|
US |
Bankruptcy Probability
Syngen Biotech Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syngen Biotech Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
S
|
Syngen Biotech Co Ltd
TPEX:8279
|
2.2B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syngen Biotech Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syngen Biotech Co Ltd has total debt of 155.3m TWD. This includes both short-term (9.6m TWD) and long-term (145.8m TWD) debt.
You can find a full breakdown on its Balance Sheet.